NCCN Guidelines® Insights Bladder Cancer, Version 5.2018 Featured Updates to the NCCN Guidelines
NCCN Guidelines® Insights Bladder Cancer, Version 5.2018 Featured Updates to the NCCN Guidelines
复制标题
DOI：
10.6004/jnccn.2018.0072
复制
发表时间：
2018-09-01
影响因子：
13.4
通讯作者：
Gurski, Lisa A.
中科院分区：
文献类型：
--
作者：
Flaig, Thomas W.;Spiess, Philippe E.;Gurski, Lisa A.
NCCN膀胱癌肿瘤临床实践指南为膀胱癌患者的诊断、评估、治疗和随访提供了建议。这些NCCN指南见解讨论了2018年版指南的重要更新，包括第8版AJCC癌症分期手册对肌肉浸润性膀胱癌治疗的影响，以及将新批准的免疫检查点抑制剂疗法纳入局部晚期或转移性疾病患者的治疗方案。
The NCCN Clinical Practice Guidelines in Oncology for Bladder Cancer provide recommendations for the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer. These NCCN Guidelines Insights discuss important updates to the 2018 version of the guidelines, including implications of the 8th edition of the AJCC Cancer Staging Manual on treatment of muscle-invasive bladder cancer and incorporating newly approved immune checkpoint inhibitor therapies into treatment options for patients with locally advanced or metastatic disease.